ASRT vs V · rev $125.0M vs P/E 33, rev $40.00B
Assertio Therapeutics Inc (ASRT) versus Visa Inc. Class A (V) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Visa Inc. Class A (V) is a credit services company listed on US. It is led by Ryan McInerney.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported V revenue for 2025-09-30 was $40.00B. Net income was $20.06B. V currently screens at market cap $659.78B and trailing P/E 33.5.
ASRT currently screens at market cap $151.5M. V currently screens at market cap $659.78B and trailing P/E 33.5.
Not investment advice. Open the ASRT and V stock pages for the full models.
Not investment advice.